Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bruce,Strober

第一单位： Yale University School of Medicine, New Haven, Connecticut, and Central Connecticut Dermatology, Cromwell, Connecticut.

作者： Bruce,Strober ^[1] ; Usha G,Mallya ^[2] ; Min,Yang ^[3] ; Sohini,Ganguli ^[2] ; Abhijit,Gadkari ^[4] ; Jessie,Wang ^[3] ; Debra,Sierka ^[2] ; Dimittri,Delevry ^[4] ; Alexa B,Kimball ^[5]

作者单位： Yale University School of Medicine, New Haven, Connecticut, and Central Connecticut Dermatology, Cromwell, Connecticut. ^[1] Sanofi, Cambridge, Massachusetts. ^[2] Analysis Group, Inc., Boston, Massachusetts. ^[3] Regeneron Pharmaceuticals Inc, Tarrytown, New York. ^[4] Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts. ^[5]

主题词成年人(Adult);队列研究(Cohort Studies);皮炎, 特应性(Dermatitis, Atopic);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);生活质量(Quality of Life);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)

DOI 10.1001/jamadermatol.2021.4778

PMID 34910086

发布时间 2022-05-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

JAMA dermatology

2022年158卷2期

142-150页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

检索历史清除